Author:
Nakashima Torahiko,Yasumatsu Ryuji,Komune Shizuo
Reference9 articles.
1. Ioka A, Tsukuma H, Ajiki W, Oshima A. Trends in head and neck cancer incidence in Japan during 1965-1999. Jpn J Clin Oncol. 2005;35:45–7.
2. Tanaka S, Sobue T. Comparison of oral and pharyngeal cancer mortality in five countries: France, Italy, Japan, UK and USA from the WHO Mortality Database (1960-2000). Jpn J Clin Oncol. 2005;35:488–91.
3. Sano H, Hamashima C. Comparison of laryngeal cancer mortality in five countries: France, Italy, Japan, UK and USA from the WHO mortality database (1960-2000). Jpn J Clin Oncol. 2005;35:626–9.
4. Bold B, Piao Y, Murata Y, Kishino M, Shibuya H. Usefulness of PET/CT for detecting a second primary cancer after treatment for squamous cell carcinoma of the head and neck. Clin Nucl Med. 2008;33:831–3.
5. Wollenberg B, Jan V, Schmit UM, Hofmann K, Stieber P, Fateh-Moghadam A. CYFRA 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer. Anticancer Res. 1996;16:3117–24.